Evidence map›Paper›PMID 36738344›Full record

ArticleAIDS and behavior2023

Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey.

Cecilia T Costiniuk, Joel Singer, Judy Needham, Yanbo Yang, Hong Qian, Catharine Chambers, Ann N Burchell, Hasina Samji, Ines Colmegna, Sugandhi Del Canto and 16 more

Open access · hybridAbstract read
In one paragraph

Article in AIDS and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. COVID-19 Incidence and Factors Influencing Infection Risk Among People Living With HIV in Türkiye: Is Current Issue the Vaccine Hesitancy-Opposition?The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Determinants of COVID-19 Vaccine Uptake Among People Living with Human Immunodeficiency Virus.Journal of the International Association of Providers of AIDS Care
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 3 countries.

Cecilia T CostiniukDeparment of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada. cecilia.costiniuk@mcgill.ca.ORCID http://orcid.org/0000-0002-4547-714X
Joel SingerSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Judy NeedhamCentre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada.
Yanbo YangFaculty of Medicine, McGill University, Montreal, QC, Canada.
Hong QianCentre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada.
Catharine ChambersDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Ann N BurchellDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Hasina SamjiBritish Columbia Centre for Disease Control, Vancouver, BC, Canada.
Ines ColmegnaDivision of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Sugandhi Del CantoCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Guy-Henri GodinCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Muluba HabanyamaCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Christian HuiCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Abigail KrochOntario HIV Treatment Network, Toronto, ON, Canada.
Enrico MandarinoCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Shari MargoleseCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Carrie MartinCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Maureen OwinoCommunity Advisory Committee, CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Tima MohammadiCentre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada.
Wei ZhangSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Sandra PelaezSchool of Kinesiology and Physical Activity Sciences, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.
Colin KovacsDivision of Infectious Diseases, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Erika BenkoThe Maple Leaf Medical Clinic, Toronto, ON, Canada.
Branka VulesevicCIHR Canadian HIV Trials Network, Vancouver, BC, Canada. bvulesevic@ohri.ca.
Curtis L CooperThe Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, ON, Canada. ccooper@toh.ca.
Aslam H AnisSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
HIV Legal Network · CASt. Paul's Hospital · CAUniversity of British Columbia · CAUniversity of Toronto · CAMcGill University Health Centre · CAOttawa Hospital · CAMaple Leaf Medical Clinic · CAMcGill University · CAOntario HIV Treatment Network · CASimon Fraser University · CAUniversité de Montréal · CA

Funding

CIHR CTN n/a
6 · The paper itself

Abstract

Understanding the roots of Covid-19 vaccine hesitancy in at-risk groups, such as persons living with HIV (PLWH), is of utmost importance. We developed a modified Vaccine Hesitancy Scale (VHS) questionnaire using items from the National Advisory Committee on Immunization Acceptability Matrix. To examine factors associated with receiving COVID-19 vaccine and the link between vaccine attitudes and beliefs with vaccine behavior, PLWH were recruited via social media and community-based organizations (February-May 2022). Descriptive statistics were used to summarize results. Total VHS score was generated by adding Likert scale scores and linear regression models used to compare results between participants who received or did not receive COVID-19 vaccines. Logistic regression models were used to identify factors associated with vaccine uptake. A total of 246 PLWH indicated whether they received a COVID-19 vaccine. 89% received ≥ 1 dose. Mean total VHS(SD) for persons having received ≥ 1 COVID-19 vaccine was 17.8(6.2) vs. 35.4(9.4) for participants not having received any COVID-19 vaccine. Persons who received ≥ 1 dose were significantly older than those who had not received any (48.4 ± 13.8 vs. 34.0 ± 7.7 years, p < 0.0001). The majority of participants considered COVID-19 vaccination important for their health(81.3%) and the health of others(84.4%). Multivariate logistic regression revealed the odds of taking ≥ 1dose were increased 2.4-fold [95% CI 1.6, 3.5] with each increase in age of 10 years (p < 0.0001). Sex and ethnicity were not different between groups. In conclusion, PLWH accept COVID-19 vaccines for both altruistic and individual reasons. With evolving recommendations and increasing numbers of booster vaccines, we must re-examine the needs of PLWH regularly.

Indexed as

COVID-19HIV InfectionsCanadaChildCOVID-19 VaccinesEthnicityHumansVaccinationCOVID-19 VaccinesCOVID-19 vaccineHIVintention to vaccinatevaccine confidencevaccine hesitancy, survey

Identifiers

PMID36738344
PMCPMC9898854
OpenAlexW4319163892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.